Pfizer Inc said on Monday that its experimental Alzheimer's disease treatment failed to prove effective in one of four high-stakes late-stage trials in patients with mild to moderate forms of the memory-robbing disease
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment